Wireless pH capsule – yield in clinical practice

Wireless pH monitoring is one of the recent technologies that focus on improving the diagnosis of gastroesophageal reflux disease (GERD). The capsule, which is fixed within the esophagus, transmits data via telemetry to an external receiver. The capsule is usually inserted 6 cm above the squamocolumnar junction during an upper endoscopy. The standard recording duration is 48 hours but this can be extended to 96 hours. The wireless capsule has been shown to be at least as accurate as the conventional catheter for the monitoring of esophageal pH. Normal pH values have been established in three different series. The use of a wireless capsule provides an increased diagnostic yield for GERD compared with the conventional catheter. The increased yield is the result of higher sensitivity to detect both abnormal acid esophageal exposure and positive symptom – reflux association. This may be related both to the prolonged recording duration and to fewer dietary modifications and restrictions on activities. Several studies have shown that the pH capsule was better tolerated by patients than the conventional pH catheter. Mild-to-moderate chest pain represents the main side effect of the pH capsule: severe chest pain requiring endoscopic removal of the capsule is rare. The main indication for wireless capsule application is monitoring of distal esophageal pH for diagnostic purpose, particularly in patients with a normal endoscopic examination. The capsule technique has some limitations: costs are higher than conventional pH monitoring, misplacement may occur, and the sampling rate is lower. Finally, compared with pH-impedance monitoring, only acid reflux events can be evaluated.

• References

• 1 Sifrim D, Castell D, Dent J et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004; 53: 1024-1031
• 2 Kwiatek MA, Pandolfino JE, Hirano I et al. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc 2010; 72: 272-278
• 3 Pandolfino JE, Richter JE, Ours T et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003; 98: 740-749
• 4 Lacy BE, O’Shana T, Hynes M et al. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor. Am J Gastroenterol 2007; 102: 24-32
• 5 Belafsky PC, Allen K, Castro-Del Rosario L et al. Wireless pH testing as an adjunct to unsedated transnasal esophagoscopy: the safety and efficacy of transnasal telemetry capsule placement. Otolaryngol Head Neck Surg 2004; 131: 26-28
• 6 Marchese M, Spada C, Iacopini F et al. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure. Endoscopy 2006; 38: 813-818
• 7 Wong WM, Bautista J, Dekel R et al. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring – a randomized trial.. Aliment Pharmacol Ther 2005; 21: 155-163
• 8 Bhat YM, McGrath KM, Bielefeldt K. Wireless esophageal pH monitoring: new technique means new questions. J Clin Gastroenterol 2006; 40: 116-121
• 9 Sweis R, Fox M, Anggiansah R et al. Patient acceptance and clinical impact of Bravo monitoring in patients with previous failed catheter-based studies. Aliment Pharmacol Ther 2009; 29: 669-676
• 10 Pandolfino JE, Lee TJ, Schreiner MA et al. Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system. Dis Esophagus 2006; 19: 177-182
• 11 Bansal A, Wani S, Rastogi A et al. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring. Am J Gastroenterol 2009; 104: 2918-2925
• 12 Wenner J, Hall M, Hoglund P et al. Wireless pH recording immediately above the squamocolumnar junction improves the diagnostic performance of esophageal pH studies. Am J Gastroenterol 2008; 103: 2977-2985
• 13 Wenner J, Johnsson F, Johansson J et al. Acid reflux immediately above the squamocolumnar junction and in the distal esophagus: simultaneous pH monitoring using the wireless capsule pH system. Am J Gastroenterol 2006; 101: 1734-1741
• 14 Doma S, Paladugu S, Parkman HP et al. Wireless capsules for esophageal pH monitoring: are we placing them correctly?. Digestion 2010; 82: 54-59
• 15 Belafsky PC, Godin DA, Garcia JC et al. Comparison of data obtained from sedated versus unsedated wireless telemetry capsule placement: does sedation affect the results of ambulatory 48-hour pH testing?. Laryngoscope 2005; 115: 1109-1113
• 16 Ayazi S, Lipham JC, Portale G et al. Bravo catheter-free pH monitoring: normal values, concordance, optimal diagnostic thresholds, and accuracy. Clin Gastroenterol Hepatol 2009; 7: 60-67
• 17 Wenner J, Johnsson F, Johansson J et al. Wireless oesophageal pH monitoring: feasibility, safety and normal values in healthy subjects. Scand J Gastroenterol 2005; 40: 768-774
• 18 Prakash C, Clouse RE. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2005; 3: 329-334
• 19 Ang D, Teo EK, Ang TL et al. To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non-erosive gastroesophageal reflux disease in a multiracial Asian cohort.. J Dig Dis 2010; 11: 19-27
• 20 Prakash C, Clouse RE. Wireless pH monitoring in patients with non-cardiac chest pain. Am J Gastroenterol 2006; 101: 446-452
• 21 Hirano I, Zhang Q, Pandolfino JE et al. Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2005; 3: 1083-1088
• 22 Calabrese C, Liguori G, Gabusi V et al. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. Aliment Pharmacol Ther 2008; 28: 250-255
• 23 Scarpulla G, Camilleri S, Galante P et al. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies. Am J Gastroenterol 2007; 102: 2642-2647
• 24 Grigolon A, Bravi I, Duca P et al. Prolonged wireless pH monitoring: importance of how to analyse oesophageal acid exposure. Scand J Gastroenterol 2010; 45: 1133-1134
• 25 Garrean CP, Zhang Q, Gonsalves N et al. Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy. Am J Gastroenterol 2008; 103: 1631-1637
• 26 Prakash C, Jonnalagadda S, Azar R et al. Endoscopic removal of the wireless pH monitoring capsule in patients with severe discomfort. Gastrointest Endosc 2006; 64: 828-832
• 27 Triester SL, Leighton JA, Budavari AI et al. Severe chest pain from an indwelling Bravo pH probe. Gastrointest Endosc 2005; 61: 317-319
• 28 Fischer A, Baier PK, Utzolino S et al. Management of severe chest pain caused by a Bravo pH monitoring capsule. Endoscopy 2008; 40 (Suppl. 02) E55-56
• 29 Wells CD, Heigh RI, Burdick GE et al. Symptomatic esophageal ulceration caused by a Bravo wireless pH probe and subsequent endoscopic removal of the probe using a retrieval net. Endoscopy 2006; 38 (02) E97
• 30 Agrawal D, Akerman PA, Rich H. Removal of a Bravo 24-hour pH capsule with endoscopic scissors. Gastrointest Endosc 2009; 70: 385-386
• 31 Tu CH, Lee YC, Wang HP et al. Ambulatory esophageal pH monitoring by using a wireless system: a pilot study in Taiwan. Hepatogastroenterology 2004; 51: 1586-1589
• 32 Iqbal A, Lee YK, Vitamvas M et al. 48-Hour pH monitoring increases the risk of false positive studies when the capsule is prematurely passed. J Gastrointest Surg 2007; 11: 638-641
• 33 Wenner J, Johansson J, Johnsson F et al. Optimal thresholds and discriminatory power of 48-h wireless esophageal pH monitoring in the diagnosis of GERD. Am J Gastroenterol 2007; 102: 1862-1869
• 34 Bruley des Varannes S, Mion F, Ducrotte P et al. Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut 2005; 54: 1682-1686
• 35 Pandolfino JE, Schreiner MA, Lee TJ et al. Comparison of the Bravo wireless and Digitrapper catheter-based pH monitoring systems for measuring esophageal acid exposure. Am J Gastroenterol 2005; 100: 1466-1476
• 36 Pandolfino JE, Zhang Q, Schreiner MA et al. Acid reflux event detection using the Bravo wireless versus the Slimline catheter pH systems: why are the numbers so different?. Gut 2005; 54: 1687-1692
• 37 Håkanson BS, Berggren P, Granqvist S et al. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring. Scand J Gastroenterol 2009; 44: 276-283
• 38 Fox M. Bravo wireless versus catheter pH monitoring systems. Gut 2006; 55: 434-435
• 39 Sweis R, Fox M, Anggiansah A et al. Prolonged, wireless pH-studies have a high diagnostic yield in patients with reflux symptoms and negative 24-h catheter-based pH-studies. Neurogastroenterol Motil 2011; 23: 419-426
• 40 Wenner J, Johnsson F, Johansson J et al. Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial. Am J Gastroenterol 2007; 102: 239-245
• 41 Grigolon A, Bravi I, Cantu P et al. Wireless pH monitoring: better tolerability and lower impact on daily habits. Dig Liver Dis 2007; 39: 720-724
• 42 Schneider JH, Kramer KM, Konigsrainer A et al. Ambulatory pH: monitoring with a wireless system. Surg Endosc 2007; 21: 2076-2080
• 43 Crowell MD, Bradley A, Hansel S et al. Obesity is associated with increased 48-h esophageal acid exposure in patients with symptomatic gastroesophageal reflux. Am J Gastroenterol 2009; 104: 553-559
• 44 Fajardo NR, Wise JL, Locke GR et al. Esophageal perforation after placement of wireless Bravo pH probe. Gastrointest Endosc 2006; 63: 184-185
• 45 Von Renteln D, Kayser T, Riecken B et al. An unusual case of Bravo capsule aspiration. Endoscopy 2008; 40 Suppl. 2: E174
• 46 Pritchett JM, Aslam M, Slaughter JC et al. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol 2009; 7: 743-748
• 47 Lee WC, Yeh YC, Lacy BE et al. Timely confirmation of gastro-esophageal reflux disease via pH monitoring: estimating budget impact on managed care organizations. Curr Med Res Opin 2008; 24: 1317-1327